Life Science Equipment Market to be Worth $92.21 Billion by 2030
o
Download Free sample Report Here:- https://www.meticulousresearch.com/download-sample-report/cp_id=3937
According to this latest publication from
Meticulous Research®, the life science equipment market is projected to reach $92.21
billion by 2030, at a CAGR of 6.2% during the forecast period. The growth of
the life science equipment is attributed to increasing funding and investment
for the pharma, biotech, and life sciences industries, government initiatives
to strengthen R&D for biotech and life sciences, increasing prevalence of
chronic diseases, and growing clinical capabilities globally.
Key Players
The key players operating in the life science
equipment market are Agilent Technologies, Inc. (U.S.), Becton, Dickinson, and
Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation
(U.S.), F. Hoffmann LA-Roche AG (Switzerland), PerkinElmer, Inc. (U.S.), Thermo
Fisher Scientific, Inc. (U.S.), Waters Corporation (U.S.), Bruker
Corporation (U.S.), Shimadzu Corporation (Japan), Siemens Healthineers AG
(Germany), Eppendorf SE (Germany), Sartorius AG (Germany), and QIAGEN N.V.
(Netherlands).
Life Science Equipment
Market: Future Outlook
The life science equipment market is
segmented by Technology [Spectroscopy, Microscopy, Chromatography, Lab
Automation, Immunoassay Analyzers, PCR, Sequencing, Flow Cytometry,
Incubators, Microarray, Centrifuges, Electrophoresis, and Other Equipment], End
User [Pharmaceutical and Biotechnology Industry, Academic & Research
Institutes, Hospitals and Diagnostic Laboratories, Analytical Testing
Laboratories, Agriculture and Food Industry, Forensic Laboratories, and Other
End Users) and Geography. The study also evaluates industry competitors and
analyzes the market at the global and regional levels. (Note: Apart from
primary segmentation, Spectroscopy, Microscopy, Chromatography, Lab
Automation, Immunoassay Analyzer, PCR, Sequencing, Flow Cytometry, Microarray,
Centrifuges, and Electrophoresis have further level segmentation).
Among the technologies
included in the report, in 2023, the spectroscopy segment is expected
to account for the largest share of the life science equipment market. The
segment's largest share is contributed by factors such as advancements in
spectroscopic technologies and growing demand for analytical techniques
coupled with increasing investment in research and development activities in
life sciences. Spectroscopy is used for drug discovery, molecular analysis,
protein characterization, metabolomics, and other important research areas in
life sciences. The increasing application areas of spectroscopy is
contributing to the segment's largest share.
Speak to analyst:- https://www.meticulousresearch.com/speak-to-analyst/cp_id=3937
Among the end users included
in the report, in 2023, the pharmaceutical and biotechnology industry
segment is expected to account for the largest share of the life science
equipment market. The largest share of the segment is attributed to the
increasing demand for technologically advanced equipment from pharmaceutical
& biotechnology companies as the demand for new therapies and drugs is
increasing. Furthermore, the pharmaceutical and biotechnology industries
constantly strive to develop new drugs and therapies to address medical needs.
Developing new drugs and therapies requires advanced laboratory equipment for
drug discovery, development, and production processes, including
high-throughput screening systems, chromatography systems, mass spectrometers,
and other specialized equipment. Hence, these factors drive the demand for
life sciences and laboratory equipment in the pharmaceutical and biotechnology
industry.
Geographic Review
This research report analyzes major
geographies and provides a comprehensive analysis of North America (U.S. and
Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and Rest of
Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of
Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and
the Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East &
Africa)
In 2023, North America is expected to account
for the largest share of the life science equipment market, followed by Europe
and Asia-Pacific. Furthermore, in 2023, the U.S. is expected to be the largest
market in North America. The presence of key players, the well-established
life science industry, substantial spending on R&D activities by the
pharmaceutical and biotech companies, and the presence of key players in the
life sciences industry contribute to the large share of this market. For
instance, in 2021, Pharmaceutical Research and Manufacturers of America
(PhRMA) member companies spent USD 102.3 billion in R&D (Source: 2022
PhRMA member annual survey).
Quick Buy: https://www.meticulousresearch.com/Checkout/26911858
Key questions answered in
the report-
· Which are
the high-growth market segments in terms of technology, end user, and
region/country?
· What was
the historical market for life science equipment across the globe?
· What are
the market forecasts and estimates for the period 2023–2030?
· What are
the major drivers, restraints, challenges, opportunities, and trends in the
global life science equipment market?
· Who are
the major players in the global life science equipment market?
· How is the
competitive landscape, and who are the market leaders in the global life
science equipment market?
· What are
the recent developments in the life science equipment market?
· What are
the different strategies adopted by the major players in the life science
equipment market?
· What are
the geographical trends and high growth regions/countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment